Witnessing the stock’s movement on the chart, on May 18, 2023, Virios Therapeutics Inc. (NASDAQ: VIRI) set off with pace as it heaved 5.77% to $1.10. During the day, the stock rose to $1.12 and sunk to $1.04 before settling in for the price of $1.04 at the close. Taking a more long-term approach, VIRI posted a 52-week range of $0.22-$9.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Nevertheless, stock’s Earnings Per Share (EPS) this year is 42.30%. This publicly-traded company’s shares outstanding now amounts to $18.33 million, simultaneously with a float of $16.12 million. The organization now has a market capitalization sitting at $20.15 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6293, while the 200-day Moving Average is $1.4895.
Virios Therapeutics Inc. (VIRI) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Virios Therapeutics Inc.’s current insider ownership accounts for 12.05%, in contrast to 17.00% institutional ownership. According to the most recent insider trade that took place on Dec 08, this organization’s Director sold 1,800 shares at the rate of 0.26, making the entire transaction reach 466 in total value, affecting insider ownership by 700. Preceding that transaction, on May 23, Company’s CHIEF EXECUTIVE OFFICER bought 7,500 for 4.52, making the whole transaction’s value amount to 33,900. This particular insider is now the holder of 32,461 in total.
Virios Therapeutics Inc. (VIRI) Earnings and Revenue Records
As on 3/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.08 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.2) by $0.12. This company achieved a return on equity of -112.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Virios Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 42.30% and is forecasted to reach -0.42 in the upcoming year.
Virios Therapeutics Inc. (NASDAQ: VIRI) Trading Performance Indicators
Let’s observe the current performance indicators for Virios Therapeutics Inc. (VIRI). It’s Quick Ratio in the last reported quarter now stands at 8.00. The Stock has managed to achieve an average true range (ATR) of 0.13.
In the same vein, VIRI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.24, a figure that is expected to reach -0.13 in the next quarter, and analysts are predicting that it will be -0.42 at the market close of one year from today.
Technical Analysis of Virios Therapeutics Inc. (VIRI)
Going through the that latest performance of [Virios Therapeutics Inc., VIRI]. Its last 5-days volume of 0.65 million was inferior to the volume of 2.03 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 51.24% While, its Average True Range was 0.1257.
Raw Stochastic average of Virios Therapeutics Inc. (VIRI) in the period of the previous 100 days is set at 72.15%, which indicates a major fall in contrast to 77.27% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 113.31% that was lower than 146.56% volatility it exhibited in the past 100-days period.
